Send The Serum Institute of India (SII) on Friday said it has suffered losses of over Rs 1,000 crore due to the devastating fire that erupted a day before at its premises here, even as Maharashtra Chief Minister Uddhav Thackeray said that whether the blaze was an accident or sabotage will be known once the probe gets over.
Photo Courtesy: Twitter/@officeofUT
Mumbai:
Five contractual labourers died in the fire that broke out in a five-storey building in the SII s Manjari premises in Pune on Thursday.Â
The chief minister visited the SII on Friday to take stock of the damages. He later addressed a press conference, where Adar Poonawalla, Chief Executive Officer (CEO) of the SII was also present.Â
Highlights
In the Serum Institute of India (SII) fire that broke out in a five-storey building in the SII s Manjari premises in Pune on January 21 (Thursday), five contractual labourers died. Maharashtra Chief Minister Uddhav Thackeray visited the SII on Friday to take stock of the damages.
The Serum Institute of India (SII) on Friday said it has suffered losses of over Rs 1,000 crore due to the devastating fire that erupted a day before at its premises in Pune, even as Maharashtra Chief Minister Uddhav Thackeray said that whether the blaze was an accident or sabotage will be known once the probe gets over.
›Serum pegs losses due to fire at over Rs 1,000 crore; Maha CM says probe in blaze on
Serum pegs losses due to fire at over Rs 1,000 crore; Maha CM says probe in blaze on
SECTIONS
Serum pegs losses due to fire at over Rs 1,000 crore; Maha CM says probe in blaze onPTI
Last Updated: Jan 22, 2021, 09:05 PM IST
Share
Synopsis
The chief minister visited the SII on Friday to take stock of the damages. He later addressed a press conference, where Adar Poonawalla, Chief Executive Officer (CEO) of the SII was also present.
ANI
Five contractual labourers died in the fire that broke out in a five-storey building in the SII s Manjari premises in Pune on Thursday.
COVID-19 Vaccine | SII, Bharat Biotech Applications For Emergency Approval 'not Considered' In Expert Panel Meeting: Report moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Expect India to approve Oxford-AstraZeneca vaccine in next few days, says SII s Cyrus Poonawalla
Britain on December 30 became the first nation to approve the Oxford University-AstraZeneca COVID-19 vaccine. December 30, 2020 / 01:48 PM IST
The Serum Institute of India (SII) expects the government to give emergency use authorisation for the Oxford-AstraZeneca vaccine in the next few days after the United Kingdom on December 30 approved the coronavirus jab for use.
Speaking to CNBC TV-18, Cyrus Poonawalla, the chairman of Poonawalla Group that includes Serum Institute of India, said, SII is expecting regulatory approval in India in the next few days.
Track this LIVE Blog for all the latest updates on coronavirus pandemicThe government was yet to place a purchase order for the Covishield vaccine, Poonawalla said. SII is ready to distribute the vaccine once the approval comes in. India will come first, then other countries, he added.